Montsanto lawsuit could also affect Swiss-based Novartis

A class action lawsuit has been launched against the biotechnology group Monsanto in the United States. The lawsuit is bound to have an impact on Novartis, which is also selling genetically mofidied seeds.

This content was published on December 15, 1999 - 07:38

This article was automatically imported from our old content management system. If you see any display errors, please let us know:

Comments under this article have been turned off. You can find an overview of ongoing debates with our journalists here. Please join us!

If you want to start a conversation about a topic raised in this article or want to report factual errors, email us at

Share this story

Join the conversation!

With a SWI account, you have the opportunity to contribute on our website.

You can Login or register here.